A "Trojan horse" therapy that sneaks toxic drugs inside cancer cells is being made available on the NHS in England in a world ...

A new immunotherapy for treating stomach cancer is helping people live 40% longer. However, some are affected by this ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

New research suggests that blood tests known as “liquid biopsies” can improve the treatment of some people with metastatic ...

Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best ...

Following a supervised exercise lowered people's risk of colon cancer recurrence by 28% in an extensive new clinical trial.

The FDA has granted approval to UGN-102 for use in patients with low-grade intermediate-risk non-muscle-invasive bladder ...

A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved ...

Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast ...

The MHRA has approved aumolertinib for adult patients with non-small cell lung cancer (NSCLC), following a groundbreaking ...

The agency set aside concerns about UroGen’s approval trial to greenlight mitomycin intravesical solution for recurrent non-muscle invasive bladder cancer.